STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

scPharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH) announced that CEO John Tucker will present at the Jefferies Virtual Healthcare Conference on June 2, 2021, at 3:30 PM EDT. The presentation aims to highlight the company's efforts to enhance the delivery of infused therapies, improve patient care, and reduce healthcare costs. Interested parties can access a live webcast through the investor relations section of scPharmaceuticals' website. The company focuses on subcutaneous, self-administration treatments for heart failure and infectious diseases.

Positive
  • None.
Negative
  • None.

BURLINGTON, Mass., May 19, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2 at 3:30 EDT.

A live webcast of the presentation can be accessed under “News and Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com


FAQ

When is the Jefferies Virtual Healthcare Conference for scPharmaceuticals scheduled?

The Jefferies Virtual Healthcare Conference for scPharmaceuticals is scheduled for June 2, 2021, at 3:30 PM EDT.

Who will present at the Jefferies Virtual Healthcare Conference for SCPH?

John Tucker, the president and CEO of scPharmaceuticals, will present at the conference.

How can I access the webcast for the scPharmaceuticals presentation?

You can access the live webcast for the scPharmaceuticals presentation by visiting the 'News and Events' section of their Investor Relations website.

What is the focus of scPharmaceuticals?

scPharmaceuticals focuses on developing products that optimize the delivery of infused therapies, enhance patient care, and reduce healthcare costs.

What kind of treatments does scPharmaceuticals work on?

scPharmaceuticals works on subcutaneous, self-administration treatments for conditions like heart failure and infectious diseases.

scPharmaceuticals Inc.

NASDAQ:SCPH

SCPH Rankings

SCPH Latest News

SCPH Stock Data

187.15M
36.70M
8.44%
74.64%
8.25%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BURLINGTON